When they conducted genetic knockdown of HSD3B1 or applied pharmacologic inhibition of 3βHSD1 with trilostane, they observed attenuation of cellular proliferation and migration of breast cancer cell lines. This evidence concerns the gene HSD3B1 and breast carcinoma.